Pfizer Upjohn Opens Global Headquarters in Shanghai
publication date: May 30, 2019
Pfizer Upjohn formally opened its new global headquarters in Shanghai, the first international headquarters of a multinational drug company located in China. Pfizer Upjohn is Pfizer's generic and off-patent drug unit. Upjohn manufactures and markets 20 of Pfizer's post-patent protected and generic products. Last year, faced with losing patent protection on Lyrica, its anti-seizure drug, Pfizer reorganized into three units: Innovative Medicines (including biosimilars); a hospital business for anti-infectives and sterile injectables; and Pfizer Upjohn for off-patent branded and generic drugs for non-communicable diseases. More details....
Stock Symbol: (NYSE: PFE)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.